Goldline Pharmaceutical Ltd. IPO

We are engaged in the business of marketing pharmaceutical products under the brand name “Goldline.” Our product portfolio is organized into five distinct segments: Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Wellness. The pharmaceutical ... products marketed under the “Goldline” brand are not manufactured by  our  Company.  Instead,  we  enter  into  contractual  arrangements  with  third-party  manufacturers,  who  produce  the products based on our market research, demand analysis, and specifications. These contractual arrangements ensure that all products meet the requisite quality standards and regulatory norms. Read more

The pharmaceutical industry in India is a significant part of the nation's foreign trade and offers lucrative potential for investors. Millions of people around the world receive affordable and inexpensive generic medications from India, which also  runs  a sizable  number  ... of  plants  that  adhere  to  Good Manufacturing  Practices  (GMP)  standards  set  by  the  World Health Organization (WHO) and the United States Food and Drug Administration (USFDA). Among nations that produce pharmaceuticals, India has long held the top spot. Medicine spending in India is projected to grow 912% over the next five  years,  leading India  to  become  one  of  the  top  10  countries  in  terms  of  medicine  spending.  Going  forward, better growth in domestic sales would also depend on the ability of companies to align their product portfolio towards chronic therapies for diseases such as such as cardiovascular, anti-diabetes, anti-depressants, and anti-cancers, which are on the rise. The Indian Government has taken many steps to reduce costs and bring down healthcare  expenses.  The National Health Protection Scheme, which aims to offer universal healthcare, the ageing population, the rise in chronic diseases, and  other  government  programmes,  including  the  opening  of  pharmacies  that  offer  inexpensive  generic  medications, should all contribute to boost the Indian pharmaceutical industry.Speedy introduction of generic drugs into the market has remained in focus and is expected to benefit the Indian pharmaceutical  companies.  In addition, the thrust on rural health programmes, lifesaving drugs and preventive vaccines also augurs well for the pharmaceutical companies. Read more